Relay Therapeutics, Inc.

RLAY

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001812364

SEC filings (opens in a new tab)

In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.

Q1 2022 vs. Q4 2021

How the institutions holding Relay Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of RLAY: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Of which not filed for Q1 2022	Q1 2022	Change
Holders	131	2	140	+11
Shares	111.0M	183.1K	113.1M	+2.30M (+2.1%)
Value	$3.41B	$5.62M	$3.38B	−$17.7M (−0.5%)

2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Relay Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to RLAY in Q1 2022
Institution	Shares	Value	% of portfolio
Nextech Invest AG	475,485	$14.2M	4.06%
Artisan Partners Limited Partnership	304,054	$9.10M	0.01%
Sessa Capital IM, L.P.	301,200	$9.02M	0.55%
Schroder Investment Management Group	84,645	$2.60M	0.00%
Barclays PLC	76,068	$2.28M	0.00%
Dimensional Fund Advisors LP	57,866	$1.73M	0.00%
Tudor Investment Corp Et Al	33,922	$1.01M	0.03%
Jane Street Group, LLC	25,763	$771.0K	0.00%
Squarepoint Ops LLC	20,926	$626.0K	0.00%
NinePointTwo Capital	17,670	$528.0K	0.14%
Amalgamated Financial Corp.	11,087	$332.0K	0.00%
E Fund Management Co., Ltd.	8,365	$250.0K	0.01%
Voloridge Investment Management, LLC	7,114	$213.0K	0.00%
Susquehanna Fundamental Investments, LLC	7,051	$211.0K	0.00%
Cutler Group LP	6,085	$182.0K	0.02%
Caption Management, LLC	5,000	$149.0K	0.01%
BIT Capital GmbH	4,500	$134.7K	0.01%
Simplex Trading, LLC	2,710	$81.0K	0.00%
US Bancorp	235	$7.00K	0.00%
Prospera Financial Services Inc	120	$4.00K	0.00%
Lindbrook Capital, LLC	102	$3.00K	0.00%
Signaturefd, LLC	51	$2.00K	0.00%
Allworth Financial LP	8	$0	0.00%
First Horizon Advisors, Inc.	16	$0	0.00%
Capital Advisors, Ltd. LLC	4	$0	0.00%
Ellevest, Inc.	11	$0	0.00%

Sold out (15)

Institutions that held Relay Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of RLAY in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Federated Hermes, Inc.	600,000	$18.4M
Fred Alger Management, LLC	177,771	$5.46M
Toronto Dominion Bank	55,643	$1.71M
Ratan Capital Management LP	50,000	$1.54M
AlphaCrest Capital Management LLC	14,253	$438.0K
Brown Advisory Inc	12,914	$397.0K
Jump Financial, LLC	10,700	$329.0K
Allstate Corp	8,600	$264.0K
XTX Topco Ltd	7,174	$220.0K
Marshall Wace, LLP	2,499	$77.0K
Russell Investments Group, Ltd.	871	$26.0K
Dark Forest Capital Management LP	453	$14.0K
Quantbot Technologies LP	100	$3.00K
Parallel Advisors, LLC	71	$2.00K
Captrust Financial Advisors	10	$0

Not filed for Q1 2022 yet (2)

Institutions that held Relay Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RLAY in Q4 2021 that haven't filed for Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Grace Capital	183,112	$5.62M
Bell Investment Advisors, Inc	35	$1.00K